can semaglutide cause frequent urination and UTI: does GLP-1 therapy increase urinary tract infection risk? How Do You Know When

Are peptide injections right for you

Remote monitoring for proactive care We extend the care experience beyond appointments with our remote monitoring tools

Declarations Funding Work in the authors laboratories was supported in part by National Institute of Diabetes and Digestive and Kidney Diseases grants R01 DK102142 (HJ) and R01 DK125465 (AR), as well as by National Institute of General Medical Sciences-funded Liver Disease COBRE grants P20 GM103549 (HJ) and P30 GM118247 (HJ)

It belongs to a class of drugs known as GLP-1 receptor agonists, which work by mimicking the action of a hormone called glucagon-like peptide-1 (GLP-1), as well as the GIP hormone